- Home
- PPC vs EXAS Comparison
PPC vs EXAS Comparison
Compare PPC & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPC
- EXAS
- Stock Information
- Founded
- PPC 1946
- EXAS 1995
- Country
- PPC United States
- EXAS United States
- Employees
- PPC N/A
- EXAS N/A
- Industry
- PPC Meat/Poultry/Fish
- EXAS Medical Specialities
- Sector
- PPC Consumer Staples
- EXAS Health Care
- Exchange
- PPC Nasdaq
- EXAS Nasdaq
- Market Cap
- PPC 12.5B
- EXAS 10.7B
- IPO Year
- PPC 1987
- EXAS N/A
- Fundamental
- Price
- PPC $44.98
- EXAS $53.17
- Analyst Decision
- PPC Hold
- EXAS Strong Buy
- Analyst Count
- PPC 6
- EXAS 20
- Target Price
- PPC $48.67
- EXAS $70.16
- AVG Volume (30 Days)
- PPC 1.1M
- EXAS 2.8M
- Earning Date
- PPC 07-30-2025
- EXAS 07-30-2025
- Dividend Yield
- PPC 14.04%
- EXAS N/A
- EPS Growth
- PPC 145.39
- EXAS N/A
- EPS
- PPC 5.08
- EXAS N/A
- Revenue
- PPC $17,979,366,000.00
- EXAS $2,828,128,000.00
- Revenue This Year
- PPC $2.74
- EXAS $14.58
- Revenue Next Year
- PPC $1.19
- EXAS $12.75
- P/E Ratio
- PPC $8.84
- EXAS N/A
- Revenue Growth
- PPC 2.40
- EXAS 11.57
- 52 Week Low
- PPC $37.28
- EXAS $39.97
- 52 Week High
- PPC $57.16
- EXAS $72.83
- Technical
- Relative Strength Index (RSI)
- PPC 39.18
- EXAS 42.14
- Support Level
- PPC $44.04
- EXAS $50.09
- Resistance Level
- PPC $46.95
- EXAS $53.20
- Average True Range (ATR)
- PPC 1.11
- EXAS 1.78
- MACD
- PPC -0.03
- EXAS -0.53
- Stochastic Oscillator
- PPC 31.97
- EXAS 24.40
About PPC Pilgrim's Pride Corporation
Pilgrim's Pride is the second-largest poultry producer in the US (59% of 2024 sales), the UK (29% including other European sales), and Mexico (12%). Its UK and European arm also includes pork operations from the 2019 acquisition of Tulip. Pilgrim's sells to chain restaurants, food processors, food distributors, and retail chains. most of its US and Mexican sales come from fresh chicken, while prepared chicken and pork constitute most of its UK and European sales. JBS owns more than 80% of Pilgrim's Pride's outstanding shares, though it failed to acquire the remaining stake in 2021 after a special board committee deemed JBS' offer undervalued Pilgrim's Pride.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.